These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 12010858
1. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D. Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858 [Abstract] [Full Text] [Related]
2. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863 [Abstract] [Full Text] [Related]
3. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG. Cancer Epidemiol Biomarkers Prev; 1998 Jun 29; 7(6):531-6. PubMed ID: 9641498 [Abstract] [Full Text] [Related]
4. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Goessl C, Krause H, Müller M, Heicappell R, Schrader M, Sachsinger J, Miller K. Cancer Res; 2000 Nov 01; 60(21):5941-5. PubMed ID: 11085508 [Abstract] [Full Text] [Related]
5. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker? Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G. Clin Chim Acta; 2004 Dec 01; 350(1-2):181-8. PubMed ID: 15530476 [Abstract] [Full Text] [Related]
6. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG. Cancer Res; 2001 Dec 15; 61(24):8611-6. PubMed ID: 11751372 [Abstract] [Full Text] [Related]
7. A quantitative promoter methylation profile of prostate cancer. Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D. Clin Cancer Res; 2004 Dec 15; 10(24):8472-8. PubMed ID: 15623627 [Abstract] [Full Text] [Related]
8. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings. Goessl C, Müller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K. J Pathol; 2002 Mar 15; 196(3):331-4. PubMed ID: 11857497 [Abstract] [Full Text] [Related]
9. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. Harden SV, Guo Z, Epstein JI, Sidransky D. J Urol; 2003 Mar 15; 169(3):1138-42. PubMed ID: 12576869 [Abstract] [Full Text] [Related]
10. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Beer TM, Evans AJ, Hough KM, Lowe BA, McWilliams JE, Henner WD. Prostate Cancer Prostatic Dis; 2002 Mar 15; 5(1):22-7. PubMed ID: 15195126 [Abstract] [Full Text] [Related]
11. GST profiling may be useful in the screening for thyroid nodule malignancy. Granja F, Morari J, Morari EC, Correa LA, Assumpção LV, Ward LS. Cancer Lett; 2004 Jun 25; 209(2):129-37. PubMed ID: 15159014 [Abstract] [Full Text] [Related]
12. Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Debes JD, Yokomizo A, McDonnell SK, Hebbring SJ, Christensen GB, Cunningham JM, Jacobsen SJ, Tindall DJ, Liu W, Schaid DJ, Thibodeau SN. Cancer Genet Cytogenet; 2004 Nov 25; 155(1):82-6. PubMed ID: 15527908 [Abstract] [Full Text] [Related]
13. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M. Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910 [Abstract] [Full Text] [Related]
14. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A. Clin Cancer Res; 2005 Jun 01; 11(11):4097-106. PubMed ID: 15930345 [Abstract] [Full Text] [Related]
15. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF. J Urol; 2002 Apr 01; 167(4):1854-8. PubMed ID: 11912447 [Abstract] [Full Text] [Related]
17. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D. Clin Cancer Res; 2001 Sep 01; 7(9):2727-30. PubMed ID: 11555585 [Abstract] [Full Text] [Related]
18. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. Srivastava DS, Mandhani A, Mittal B, Mittal RD. BJU Int; 2005 Jan 01; 95(1):170-3. PubMed ID: 15638917 [Abstract] [Full Text] [Related]
19. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Meiers I, Shanks JH, Bostwick DG. Pathology; 2007 Jun 01; 39(3):299-304. PubMed ID: 17558856 [Abstract] [Full Text] [Related]
20. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis. Gonzalgo ML, Nakayama M, Lee SM, De Marzo AM, Nelson WG. Urology; 2004 Feb 01; 63(2):414-8. PubMed ID: 14972513 [Abstract] [Full Text] [Related] Page: [Next] [New Search]